Project

Charcot Stichting - Fund 2022: Investigating itaconic acid as a critical immunometabolite in multiple sclerosis

Code
365F00121
Duration
01 January 2022 → 31 December 2023
Funding
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Autoimmunity
    • Inflammation
    • Innate immunity
    • Cell signalling
Keywords
multiple sclerosis microglia inflammation metabolite itaconate Irg1
 
Project description

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system. Macrophages derived from infiltrating monocytes and resident microglia contribute to the inflammatory reactions in MS. In this project, we will focus on the role and importance of the metabolite itaconate as an anti-inflammatory protective mechanism induced by activated macrophages and microglia during MS.

By studying the molecular mechanisms behind macrophage and microglia activation, we hope to contribute to a better knowledge on MS which may help in the development of better therapies to treat the disease.